SMTL ID : 5mtx.1

Dibenzooxepinone inhibitor 12b in complex with p38 MAPK

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x FJI: 3-[(3-benzamido-4-fluoranyl-phenyl)amino]-~{N}-(2-morpholin-4-ylethyl)-11-oxidanylidene-6~{H}-benzo[c][1]benzoxepine-9-carboxamide(Non-covalent)

FJI.1: 17 residues within 4Å: Chain A: V.30, A.51, K.53, E.71, L.74, L.75, I.84, L.104, T.106, H.107, L.108, M.109, G.110, A.111, L.167, D.168, F.169 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:V.30, A:A.51, A:K.53, A:E.71, A:L.74, A:L.75, A:T.106, A:L.108, A:L.167, A:L.167 Hydrogen bonds: A:K.53, A:E.71, A:M.109, A:G.110, A:D.168, A:D.168 Water bridges: A:D.168 pi-Stacking: A:F.169

2 x BOG: octyl beta-D-glucopyranoside(Non-covalent)

BOG.2: 11 residues within 4Å: Chain A: E.192, W.197, M.198, H.199, Y.200, L.246, K.249, L.291, D.292, S.293, D.294 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:W.197, A:W.197, A:L.246 Hydrogen bonds: A:H.199, A:D.292, A:S.293 Water bridges: A:N.201, A:S.293 BOG.3: 10 residues within 4Å: Chain A: L.195, N.196, W.197, H.199, K.249, I.250, S.251, A.255, Y.258, I.259 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.195, A:A.255, A:Y.258, A:I.259 Hydrogen bonds: A:K.249, A:S.251 Water bridges: A:S.252

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Walter, N.M. et al., Design, Synthesis, and Biological Evaluation of Novel Type I(1)/2 p38 alpha MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine. J. Med. Chem. (2017)

Release Date

2017-09-06

Peptides

Mitogen-activated protein kinase 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 14

Related Entries With Identical Sequence